DOD cancer research programs face 57% funding cut in year-long continuing resolution Pancreatic, lung, kidney cancer research programs eliminated

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

We are at a transformational period in oncology; the overall mortality from cancer is gradually declining in the United States.

April 25, 2025

Vol.51 No.16

By Suresh S. Ramalingam and Adam Marcus

Advancing peritoneal oncology: Innovations in surgical strategies and research

Peritoneal metastases arise from gastrointestinal and gynecologic malignancies, leading to debilitating symptoms and poor prognoses. They remain one of the most challenging manifestations of advanced malignancies, often leading to significant morbidity and limited treatment options.

NSF director Sethuraman Panchanathan to resign

Sethuraman Panchanathan, director of the National Science Foundation, will resign from the position 16 months before the scheduled end of his six-year term.

April 25, 2025

Vol.51 No.16

By Jacquelyn Cobb and Claire Marie Porter

In Brief

William Hait named AACR chief scientific advisor

William N. Hait was named as chief scientific advisor to the American Association for Cancer Research.

April 25, 2025

Vol.51 No.16

Funding Opportunities

2025 AACR-Novocure grants for cancer research now accepting applications

The American Association for Cancer Research-Novocure Career Development Award for Cancer Research represents a joint effort to promote and support early-career investigators who are conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells) as well as to encourage early-career investigators to enter the TTFields research field.

April 25, 2025

Vol.51 No.16

Clinical Roundup

Research points to novel strategy for treating metastatic medulloblastoma

Researchers at Baylor College of Medicine, Texas Children’s Hospital, the Hospital for Sick Children in Toronto and collaborating institutions revealed in Nature Cell Biology a strategy that helps medulloblastoma, the most prevalent malignant brain tumor in children, spread and grow on the leptomeninges, the membranes surrounding the brain and spinal cord.

April 25, 2025

Vol.51 No.16

DOD cancer research programs face 57% funding cut in year-long continuing resolution

Pancreatic, lung, kidney cancer research programs eliminated

YOU MAY BE INTERESTED IN

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

Advancing peritoneal oncology: Innovations in surgical strategies and research

NSF director Sethuraman Panchanathan to resign

William Hait named AACR chief scientific advisor

2025 AACR-Novocure grants for cancer research now accepting applications

Research points to novel strategy for treating metastatic medulloblastoma

Renew today!

Subscriber content

Never miss an issue!

Login